Glucocorticoids enhance airway epithelial barrier integrity

International Immunopharmacology - Tập 12 - Trang 350-357 - 2012
Akiko Sekiyama1, Yasuhiro Gon1,2, Masahiro Terakado1, Ikuko Takeshita1, Yutaka Kozu1, Shuichiro Maruoka1, Ken Matsumoto1, Shu Hashimoto1
1Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Japan
2Division of General Internal Medicine, Department of Internal Medicine, Nihon University School of Medicine, Japan

Tài liệu tham khảo

Bousquet, 2000, Asthma. From bronchoconstriction to airways inflammation and remodeling, Am J Respir Crit Care Med, 161, 1720, 10.1164/ajrccm.161.5.9903102 Kim, 2010, The many paths to asthma: phenotype shaped by innate and adaptive immunity, Nat Immunol, 11, 577, 10.1038/ni.1892 Barnes, 1998, Efficacy and safety of inhaled corticosteroids. New developments, Am J Respir Crit Care Med, 157, S1, 10.1164/ajrccm.157.3.157315 Pauwels, 2001, The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale and design, Control Clin Trials, 22, 405, 10.1016/S0197-2456(01)00144-1 Jeffery, 1992, Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study, Am Rev Respir Dis, 145, 890, 10.1164/ajrccm/145.4_Pt_1.890 Schleimer, 1990, Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma, Am Rev Respir Dis, 141, S59 Schwiebert, 1996, Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions, J Allergy Clin Immunol, 97, 143, 10.1016/S0091-6749(96)80214-4 Coyne, 2002, Regulation of airway tight junctions by proinflammatory cytokines, Mol Biol Cell, 13, 3218, 10.1091/mbc.e02-03-0134 Holgate, 2007, Epithelium dysfunction in asthma, J Allergy Clin Immunol, 120, 1233, 10.1016/j.jaci.2007.10.025 Verheggen, 1996, Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1 beta, TNF-alpha and LPS, Eur Respir J, 9, 2036, 10.1183/09031936.96.09102036 Pujolsa, 2009, Glucocorticoid receptor in human respiratory epithelial cells, Neuroimmunomodulation, 16, 290, 10.1159/000216187 Bazzoni, 2004, Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis, Physiol Rev, 84, 869, 10.1152/physrev.00035.2003 Tsukita, 2001, Multifunctional strands in tight junctions, Nat Rev Mol Cell Biol, 2, 285, 10.1038/35067088 Tsukita, 2008, Tight junction-based epithelial microenvironment and cell proliferation, Oncogene, 27, 6930, 10.1038/onc.2008.344 Xiao, 2011, Defective epithelial barrier function in asthma, J Allergy Clin Immunol, 128, 549, 10.1016/j.jaci.2011.05.038 Swindle, 2009, Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches, J Allergy Clin Immunol, 124, 23, 10.1016/j.jaci.2009.05.037 Laitinen, 1992, A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial, J Allergy Clin Immunol, 90, 32, 10.1016/S0091-6749(06)80008-4 Cozens, 1994, CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells, Am J Respir Cell Mol Biol, 10, 38, 10.1165/ajrcmb.10.1.7507342 Holliday, 1994, Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma, Drugs, 47, 318, 10.2165/00003495-199447020-00007 Clissold, 1984, Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis, Drugs, 28, 485, 10.2165/00003495-198428060-00001 Artursson, 1994, Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2), Pharm Res, 11, 1358, 10.1023/A:1018967116988 Gibson, 2001, Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial, Am J Respir Crit Care Med, 163, 32, 10.1164/ajrccm.163.1.9807061 Barnes, 1998, Relative safety and efficacy of inhaled corticosteroids, J Allergy Clin Immunol, 101, S460, 10.1016/S0091-6749(98)70160-5 Lawrence, 1997, Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity, Am J Respir Crit Care Med, 156, 744, 10.1164/ajrccm.156.3.9608058 Basuroy, 2006, MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide, Biochem J, 393, 69, 10.1042/BJ20050959 Tillie-Leblond, 2007, Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats, Eur Respir J, 30, 31, 10.1183/09031936.00011606 Terakado, 2011, The Rac1/JNK pathway is critical for EGFR-dependent barrier formation in human airway epithelial cells, Am J Physiol Lung Cell Mol Physiol, 300, L56, 10.1152/ajplung.00159.2010 Roche, 1993, Cell adhesion molecules and the bronchial epithelium, Am Rev Respir Dis, 148, S79, 10.1164/ajrccm/148.6_Pt_2.S79 Gonzalez-Mariscal, 2000, MAGUK proteins: structure and role in the tight junction, Semin Cell Dev Biol, 11, 315, 10.1006/scdb.2000.0178 Scheving, 2007, Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes, Am J Physiol Gastrointest Liver Physiol, 293, G552, 10.1152/ajpgi.00140.2007 Kassel, 2009, Modulation of epidermal growth factor receptor binding to human airway smooth muscle cells by glucocorticoids and beta2-adrenergic receptor agonists, Am J Physiol Lung Cell Mol Physiol, 296, L693, 10.1152/ajplung.90446.2008